Rosuvastatin/Omega-3-Acid Ethyl Esters

瑞舒伐他汀/ω-3酸乙酯

Report date: 2022/07/19 16:22:54

Base Information

Drug NameRosuvastatin/Omega-3-Acid Ethyl Esters
Drug Alias NameRosuvastatin and Omega-3-Acid Ethyl Estersω-3酸乙酯/瑞舒伐他汀瑞舒伐他汀+ω-3酸乙酯Rosuvastatin●Omega-3-Acid Ethyl Esters瑞舒伐他汀-ω-3酸乙酯 +[11] 
ClassificationSmall molecules
Mechanisms of ActionTriglyceride modulatorsLipid modulatorsHMG-CoA reductase inhibitors
TargetsHMG-CoA reductaseTriglycerideLipid
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Rosuvastatin CalciumOmega-3-acid ethyl esters (Trygg Pharma)
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanmi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A